The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Realizing the promise of cancer predisposition genes
Open accessAbstract
Genes in which germline mutations confer highly or moderately increased risks of cancer are called cancer predisposition genes. More than 100 of these genes have been identified, providing important scientific insights in many areas, particularly the mechanisms of cancer causation. Moreover, clinical utilization of cancer predisposition genes has had a substantial impact on diagnosis, optimized management and prevention of cancer. The recent transformative advances in DNA sequencing hold the promise of many more cancer predisposition gene discoveries, and greater and broader clinical applications. However, there is also considerable potential for incorrect inferences and inappropriate clinical applications. Realizing the promise of cancer predisposition genes for science and medicine will thus require careful navigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
An integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Hindorff, L. A., Sethupathy, P., Junkins, H. A., Ramos, E. M., Mehta, J. P., Collins, F. S., & Manolio, T. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903103106 · Cited by 4,013
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Biological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
Principles and Practice of Screening for Disease.
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-5-1085_2 · Cited by 3,066
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301749 · Cited by 3,037
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,541
International network of cancer genome projects
The International Cancer Genome Consortium (2010) · Nature · doi:10.1038/nature08987 · Cited by 2,299
the DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Morris, A. P., Voight, B. F., Teslovich, T. M., Ferreira, T., Segrè, A. V., Steinthorsdottir, V., Strawbridge, R. J., Khan, H., Grallert, H., et al. (2012) · Nature Genetics · doi:10.1038/ng.2383 · Cited by 1,912
Human Homolog of patched , a Candidate Gene for the Basal Cell Nevus Syndrome
Johnson, R. L., Rothman, A. L., Xie, J., Goodrich, L. V., Bare, J. W., Bonifas, J. M., Quinn, A. G., Myers, R. M., Cox, D. R., Epstein, E. H., et al. (1996) · Science · doi:10.1126/science.272.5268.1668 · Cited by 1,857
TERT Promoter Mutations in Familial and Sporadic Melanoma
Horn, S., Figl, A., Rachakonda, P. S., Fischer, C., Sucker, A., Gast, A., Kadel, S., Moll, I., Nagore, E., Hemminki, K., et al. (2013) · Science · doi:10.1126/science.1230062 · Cited by 1,799
Positional Cloning of the Werner's Syndrome Gene
Yu, C.-E., Oshima, J., Fu, Y.-H., Wijsman, E. M., Hisama, F., Alisch, R., Matthews, S., Nakura, J., Miki, T., Ouais, S., et al. (1996) · Science · doi:10.1126/science.272.5259.258 · Cited by 1,722
Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene
Whitcomb, D. C., Gorry, M. C., Preston, R. A., Furey, W., Sossenheimer, M. J., Ulrich, C. D., Martin, S. P., Gates, L. K., Amann, S. T., Toskes, P. P., et al. (1996) · Nature Genetics · doi:10.1038/ng1096-141 · Cited by 1,628
Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer
Nicolaides, N. C., Papadopoulos, N., Liu, B., Weit, Y.-F., Carter, K. C., Ruben, S. M., Rosen, C. A., Haseltine, W. A., Fleischmann, R. D., Fraser, C. M., et al. (1994) · Nature · doi:10.1038/371075a0 · Cited by 1,545
Cancer Risks in BRCA2 Mutation Carriers
Breast Cancer Linkage Consortium, T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1310 · Cited by 1,527
Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors
Al-Tassan, N., Chmiel, N. H., Maynard, J., Fleming, N., Livingston, A. L., Williams, G. T., Hodges, A. K., Davies, D. R., David, S. S., Sampson, J. R., et al. (2002) · Nature Genetics · doi:10.1038/ng828 · Cited by 1,394
Principles and Practice of Screening for Disease.
Zavon, M. R. (1969) · Archives of Internal Medicine · doi:10.1001/archinte.1969.00300130131020 · Cited by 1,356
The CHEK2-Breast Cancer Consortium (2002) · Nature Genetics · doi:10.1038/ng879 · Cited by 1,104
Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome
Aiuti, A., Biasco, L., Scaramuzza, S., Ferrua, F., Cicalese, M. P., Baricordi, C., Dionisio, F., Calabria, A., Giannelli, S., Castiello, M. C., et al. (2013) · Science · doi:10.1126/science.1233151 · Cited by 1,025
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
The Breast Cancer Susceptibility Collaboration (UK), Rahman, N., Seal, S., Thompson, D., Kelly, P., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., et al. (2007) · Nature Genetics · doi:10.1038/ng1959 · Cited by 1,003
Self-citationThe Catalogue of Somatic Mutations in Cancer (COSMIC)
Forbes, S. A., Bhamra, G., Bamford, S., Dawson, E., Kok, C., Clements, J., Menzies, A., Teague, J. W., Futreal, P. A., & Stratton, M. R. (2008) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1011s57 · Cited by 904
Mutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875
Rausch, T., Jones, D. T. W., Zapatka, M., Stütz, A. M., Zichner, T., Weischenfeldt, J., Jäger, N., Remke, M., Shih, D., Northcott, P. A., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.013 · Cited by 865
Castro, E., Goh, C., Olmos, D., Saunders, E., Leongamornlert, D., Tymrakiewicz, M., Mahmud, N., Dadaev, T., Govindasami, K., Guy, M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.1882 · Cited by 850
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
Zuo, L., Weger, J., Yang, Q., Goldstein, A. M., Tucker, M. A., Walker, G. J., Hayward, N., & Dracopoli, N. C. (1996) · Nature Genetics · doi:10.1038/ng0196-97 · Cited by 818
Mutations in SUFU predispose to medulloblastoma
Taylor, M. D., Liu, L., Raffel, C., Hui, C.-C., Mainprize, T. G., Zhang, X., Agatep, R., Chiappa, S., Gao, L., Lowrance, A., et al. (2002) · Nature Genetics · doi:10.1038/ng916 · Cited by 806
Zur Frage der Entstehung maligner Tumoren
Boveri, T. (1914) · Cited by 801
Structural Evidence for the Authenticity of the Human Retinoblastoma Gene
Fung, Y.-K. T., Murphree, A. L., T'Ang, A., Qian, J., Hinrichs, S. H., & Benedict, W. F. (1987) · Science · doi:10.1126/science.2885916 · Cited by 780
Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome
Pilia, G., Hughes-Benzie, R. M., MacKenzie, A., Baybayan, P., Chen, E. Y., Huber, R., Neri, G., Cao, A., Forabosco, A., & Schlessinger, D. (1996) · Nature Genetics · doi:10.1038/ng0396-241 · Cited by 761
The Breast Cancer Susceptibility Collaboration (UK), Seal, S., Thompson, D., Renwick, A., Elliott, A., Kelly, P., Barfoot, R., Chagtai, T., Jayatilake, H., Ahmed, M., et al. (2006) · Nature Genetics · doi:10.1038/ng1902 · Cited by 746
Self-citationGermline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer
Miyaki, M., Konishi, M., Tanaka, K., Kikuchi-Yanoshita, R., Muraoka, M., Yasuno, M., Igari, T., Koike, M., Chiba, M., & Mori, T. (1997) · Nature Genetics · doi:10.1038/ng1197-271 · Cited by 726
Germline mutations in BAP1 predispose to melanocytic tumors
Wiesner, T., Obenauf, A. C., Murali, R., Fried, I., Griewank, K. G., Ulz, P., Windpassinger, C., Wackernagel, W., Loy, S., Wolf, I., et al. (2011) · Nature Genetics · doi:10.1038/ng.910 · Cited by 725
SDH5 , a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma
Hao, H.-X., Khalimonchuk, O., Schraders, M., Dephoure, N., Bayley, J.-P., Kunst, H., Devilee, P., Cremers, C. W. R. J., Schiffman, J. D., Bentz, B. G., et al. (2009) · Science · doi:10.1126/science.1175689 · Cited by 702
Germline mutations in HRAS proto-oncogene cause Costello syndrome
Aoki, Y., Niihori, T., Kawame, H., Kurosawa, K., Ohashi, H., Tanaka, Y., Filocamo, M., Kato, K., Suzuki, Y., Kure, S., et al. (2005) · Nature Genetics · doi:10.1038/ng1641 · Cited by 679
Mavaddat, N., Barrowdale, D., Andrulis, I. L., Domchek, S. M., Eccles, D., Nevanlinna, H., Ramus, S. J., Spurdle, A., Robson, M., Sherman, M., et al. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0775 · Cited by 669
Sequence variants at the TERT-CLPTM1L locus associate with many cancer types
Rafnar, T., Sulem, P., Stacey, S. N., Geller, F., Gudmundsson, J., Sigurdsson, A., Jakobsdottir, M., Helgadottir, H., Thorlacius, S., Aben, K. K. H., et al. (2009) · Nature Genetics · doi:10.1038/ng.296 · Cited by 609
Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B
Hanks, S., Coleman, K., Reid, S., Plaja, A., Firth, H., FitzPatrick, D., Kidd, A., Méhes, K., Nash, R., Robin, N., et al. (2004) · Nature Genetics · doi:10.1038/ng1449 · Cited by 605
Self-citationFamilial gastrointestinal stromal tumours with germline mutation of the KIT gene
Nishida, T., Hirota, S., Taniguchi, M., Hashimoto, K., Isozaki, K., Nakamura, H., Kanakura, Y., Tanaka, T., Takabayashi, A., Matsuda, H., et al. (1998) · Nature Genetics · doi:10.1038/1209 · Cited by 586
Xeroderma Pigmentosum Group F Caused by a Defect in a Structure-Specific DNA Repair Endonuclease
Sijbers, A. M., de Laat, W. L., Ariza, R. R., Biggerstaff, M., Wei, Y.-F., Moggs, J. G., Carter, K. C., Shell, B. K., Evans, E., de Jong, M. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80155-5 · Cited by 548
Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome
Tang, J. Y., Mackay-Wiggan, J. M., Aszterbaum, M., Yauch, R. L., Lindgren, J., Chang, K., Coppola, C., Chanana, A. M., Marji, J., Bickers, D. R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113538 · Cited by 547
Germline mutations in RAD51D confer susceptibility to ovarian cancer
Breast Cancer Susceptibility Collaboration (UK), Loveday, C., Turnbull, C., Ramsay, E., Hughes, D., Ruark, E., Frankum, J. R., Bowden, G., Kalmyrzaev, B., Warren-Perry, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.893 · Cited by 534
Self-citationBell, D. W., Gore, I., Okimoto, R. A., Godin-Heymann, N., Sordella, R., Mulloy, R., Sharma, S. V., Brannigan, B. W., Mohapatra, G., Settleman, J., et al. (2005) · Nature Genetics · doi:10.1038/ng1671 · Cited by 531
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
Comino-Méndez, I., Gracia-Aznárez, F. J., Schiavi, F., Landa, I., Leandro-García, L. J., Letón, R., Honrado, E., Ramos-Medina, R., Caronia, D., Pita, G., et al. (2011) · Nature Genetics · doi:10.1038/ng.861 · Cited by 526
Wells, S. A., Gosnell, J. E., Gagel, R. F., Moley, J., Pfister, D., Sosa, J. A., Skinner, M., Krebs, A., Vasselli, J., & Schlumberger, M. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.6604 · Cited by 519
A continuum model for tumour suppression
Berger, A. H., Knudson, A. G., & Pandolfi, P. P. (2011) · Nature · doi:10.1038/nature10275 · Cited by 501
Variation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers
Thompson, D., & Easton, D. (2001) · The American Journal of Human Genetics · doi:10.1086/318181 · Cited by 489
Succinate dehydrogenase – Assembly, regulation and role in human disease
Rutter, J., Winge, D. R., & Schiffman, J. D. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.03.001 · Cited by 462
Armanios, M., Chen, J.-L., Chang, Y.-P. C., Brodsky, R. A., Hawkins, A., Griffin, C. A., Eshleman, J. R., Cohen, A. R., Chakravarti, A., Hamosh, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508124102 · Cited by 452
Constitutional Mutations of the hSNF5/INI1 Gene Predispose to a Variety of Cancers
Sévenet, N., Sheridan, E., Amram, D., Schneider, P., Handgretinger, R., & Delattre, O. (1999) · The American Journal of Human Genetics · doi:10.1086/302639 · Cited by 450
Hunter, C., Smith, R., Cahill, D. P., Stephens, P., Stevens, C., Teague, J., Greenman, C., Edkins, S., Bignell, G., Davies, H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0127 · Cited by 434
Somatic HIF2A Gain-of-Function Mutations in Paraganglioma with Polycythemia
Zhuang, Z., Yang, C., Lorenzo, F., Merino, M., Fojo, T., Kebebew, E., Popovic, V., Stratakis, C. A., Prchal, J. T., & Pacak, K. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205119 · Cited by 397
Niemeyer, C. M., Kang, M. W., Shin, D. H., Furlan, I., Erlacher, M., Bunin, N. J., Bunda, S., Finklestein, J. Z., Sakamoto, K. M., Gorr, T. A., et al. (2010) · Nature Genetics · doi:10.1038/ng.641 · Cited by 374
(2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1167 · Cited by 372
Couch, F. J., Wang, X., McGuffog, L., Lee, A., Olswold, C., Kuchenbaecker, K. B., Soucy, P., Fredericksen, Z., Barrowdale, D., Dennis, J., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003212 · Cited by 371
Slade, I., Bacchelli, C., Davies, H., Murray, A., Abbaszadeh, F., Hanks, S., Barfoot, R., Burke, A., Chisholm, J., Hewitt, M., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2010.083790 · Cited by 371
Self-citationZur Frage der Entstehung maligner Tumoren
Ribbert, H., & Bally, W. (1914) · Die Naturwissenschaften · doi:10.1007/bf01497322 · Cited by 340
The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes
Stickens, D., Clines, G., Burbee, D., Ramos, P., Thomas, S., Hogue, D., Hecht, J. T., Lovett, M., & Evans, G. A. (1996) · Nature Genetics · doi:10.1038/ng0996-25 · Cited by 338
Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update
Wells, S. A., Pacini, F., Robinson, B. G., & Santoro, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1204 · Cited by 338
Mutation of CEBPA in Familial Acute Myeloid Leukemia
Smith, M. L., Cavenagh, J. D., Lister, T. A., & Fitzgibbon, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041331 · Cited by 328
Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour
Scott, R. H., Stiller, C. A., Walker, L., & Rahman, N. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.041723 · Cited by 322
Self-citationA germline variant in the TP53 polyadenylation signal confers cancer susceptibility
Swedish Low-risk Colorectal Cancer Study Group, Stacey, S. N., Sulem, P., Jonasdottir, A., Masson, G., Gudmundsson, J., Gudbjartsson, D. F., Magnusson, O. T., Gudjonsson, S. A., Sigurgeirsson, B., et al. (2011) · Nature Genetics · doi:10.1038/ng.926 · Cited by 295
Antoniou, A. C., Spurdle, A. B., Sinilnikova, O. M., Healey, S., Pooley, K. A., Schmutzler, R. K., Versmold, B., Engel, C., Meindl, A., Arnold, N., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.02.008 · Cited by 283
Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene
Huff, V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3002 · Cited by 266
Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas
Smith, M. J., O'Sullivan, J., Bhaskar, S. S., Hadfield, K. D., Poke, G., Caird, J., Sharif, S., Eccles, D., Fitzpatrick, D., Rawluk, D., et al. (2013) · Nature Genetics · doi:10.1038/ng.2552 · Cited by 261
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer
The Breast and Ovarian Cancer Susceptibility Collaboration, Ruark, E., Wellcome Trust Case Control Consortium, Snape, K., Humburg, P., Loveday, C., Bajrami, I., Brough, R., Rodrigues, D. N., Renwick, A., et al. (2013) · Nature · doi:10.1038/nature11725 · Cited by 248
Self-citationPacini, F., Castagna, M. G., Cipri, C., & Schlumberger, M. (2010) · Clinical Oncology · doi:10.1016/j.clon.2010.05.002 · Cited by 245
Genome-wide association study identifies three new melanoma susceptibility loci
Barrett, J. H., Iles, M. M., Harland, M., Taylor, J. C., Aitken, J. F., Andresen, P. A., Akslen, L. A., Armstrong, B. K., Avril, M.-F., Azizi, E., et al. (2011) · Nature Genetics · doi:10.1038/ng.959 · Cited by 240
PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor
Chompret, A., Kannengiesser, C., Barrois, M., Terrier, P., Dahan, P., Tursz, T., Lenoir, G. M., & Bressac-De Paillerets, B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.079 · Cited by 237
Targeting PI3 Kinase/AKT/mTOR Signaling in Cancer
Sheppard, K., Kinross, K. M., Solomon, B., Pearson, R. B., & Phillips, W. A. (2012) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v17.i1.60 · Cited by 225
RB1 gene mutations in retinoblastoma
Lohmann, D. R. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(199910)14:4<283::aid-humu2>3.0.co;2-j · Cited by 214
Byrski, T., Dent, R., Blecharz, P., Foszczynska-Kloda, M., Gronwald, J., Huzarski, T., Cybulski, C., Marczyk, E., Chrzan, R., Eisen, A., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3231 · Cited by 210
Factors Associated with Childhood Tumours (FACT) Collaboration, Scott, R. H., Douglas, J., Baskcomb, L., Huxter, N., Barker, K., Hanks, S., Craft, A., Gerrard, M., Kohler, J. A., et al. (2008) · Nature Genetics · doi:10.1038/ng.243 · Cited by 199
Self-citationPenetrance of adrenocortical tumours associated with the germline TP53 R337H mutation
Figueiredo, B. C., Sandrini, R., Zambetti, G. P., Pereira, R. M., Cheng, C., Liu, W., Lacerda, L., Pianovski, M. A., Michalkiewicz, E., Jenkins, J., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2004.030551 · Cited by 166
Benusiglio, P. R., Malka, D., Rouleau, É., Pauw, A. D., Buecher, B., Noguès, C., Fourme, E., Colas, C., Coulet, F., Warcoin, M., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101472 · Cited by 166
Evidence for WT1 as a Wilms tumor (WT) gene: intragenic germinal deletion in bilateral WT.
Huff, V., Miwa, H., Haber, D. A., Call, K. M., Housman, D. E., Strong, L. C., & Saunders, G. F. (1991) · Europe PMC (PubMed Central) · Cited by 165
Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer
Gaudet, M. M., Kirchhoff, T., Green, T., Vijai, J., Korn, J. M., Guiducci, C., Segrè, A. V., McGee, K., McGuffog, L., Kartsonaki, C., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001183 · Cited by 162
Goudie, D. R., D’Alessandro, M., Merriman, B., Lee, H., Szeverényi, I., Avery, S., O’Connor, B. D., Nelson, S. F., Coats, S. E., Stewart, A., et al. (2011) · Nature Genetics · doi:10.1038/ng.780 · Cited by 157
Mutations Specific to the Xeroderma Pigmentosum Group E Ddb− Phenotype
Nichols, A. F., Ong, P., & Linn, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24317 · Cited by 154
D, S. M. M., Verdi, D., Pooley, K. A., Landi, M. T., Egan, K. M., Baird, D. M., Prescott, J., Vivo, I. D., & Nitti, D. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs222 · Cited by 144
Dyskeratosis congenita as a disorder of telomere maintenance
Nelson, N. D., & Bertuch, A. A. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.06.008 · Cited by 141
Genome-wide association studies in common cancers—what have we learnt?
Varghese, J. S., & Easton, D. F. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.03.012 · Cited by 120
Searching for synthetic lethality in cancer
Brough, R., Frankum, J. R., Costa-Cabral, S., Lord, C. J., & Ashworth, A. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.009 · Cited by 118
Stratification of Wilms tumor by genetic and epigenetic analysis
Scott, R. H., Murray, A., Baskcomb, L., Turnbull, C., Loveday, C., Al‐Saadi, R., Williams, R. D., Breatnach, F., Gerrard, M., Hale, J., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.468 · Cited by 114
Self-citationJafri, M., & Maher, E. R. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0497 · Cited by 107
Broca, P. (1866) · Cited by 106
Hafner, C. M., & Groesser, L. (2012) · Cell Cycle · doi:10.4161/cc.23108 · Cited by 98
Rahman, N., & Scott, R. H. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm026 · Cited by 95
Self-citationReade, C. J., Riva, J. J., Busse, J. W., Goldsmith, C. H., & Elit, L. M. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.06.029 · Cited by 92
Sequence and Structure Signatures of Cancer Mutation Hotspots in Protein Kinases
Dixit, A., Yi, L., Gowthaman, R., Torkamani, A., Schork, N. J., & Verkhivker, G. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007485 · Cited by 90
The inherited genetics of ovarian and endometrial cancer
Gayther, S. A., & Pharoah, P. D. P. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.03.001 · Cited by 89
Cancer syndromes and therapy by stop-codon readthrough
Bordeira–Carriço, R., Pêgo, A. P., Santos, M. A. S., & Oliveíra, C. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.09.004 · Cited by 80
SWI/SNF complex in disorder: SWItching from malignancies to intellectual disability
Santen, G. W. E., Kriek, M., & van Attikum, H. (2012) · Epigenetics · doi:10.4161/epi.22299 · Cited by 79
Platinum chemotherapy for BRCA1-related breast cancer: do we need more evidence?
Turner, N. C., & Tutt, A. N. J. (2012) · Breast Cancer Research · doi:10.1186/bcr3332 · Cited by 76
Seevaratnam, R., Coburn, N. G., Cardoso, R., Dixon, M. E. B., Bocicariu, A., & Helyer, L. K. (2011) · Gastric Cancer · doi:10.1007/s10120-011-0116-3 · Cited by 71
Chemoprevention in Lynch syndrome
Burn, J., Mathers, J. C., & Bishop, D. T. (2013) · Familial Cancer · doi:10.1007/s10689-013-9650-y · Cited by 67
Chang, C. Q., Yesupriya, A., Rowell, J. L., Pimentel, C. B., Clyne, M., GWINN, M. L., Khoury, M. J., Wulf, A., & Schully, S. D. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.161 · Cited by 65
Snape, K. M. G., Ruark, E., Tarpey, P. S., Renwick, A., Turnbull, C., Seal, S., Murray, A., Hanks, S., Douglas, J. B., Stratton, M. R., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2057-x · Cited by 63
Self-citationBachet, J., Landi, B., Laurent‐Puig, P., Italiano, A., Cesne, A. L., Lévy, P., Safar, V., Duffaud, F., Blay, J., & Emile, J. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.04.005 · Cited by 57
Gene–gene interactions in breast cancer susceptibility
Turnbull, C., Seal, S., Renwick, A., Warren-Perry, M., Hughes, D., Elliott, A., Pernet, D., Peock, S., Adlard, J., Barwell, J., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr525 · Cited by 53
Self-citationMoorman, P. G., Iversen, E. S., Marcom, P. K., Marks, J. R., Wang, F. M., Lee, E., Ursin, G., Rebbeck, T. R., Domchek, S. M., Arun, B., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0842-y · Cited by 40
The association between ATM D1853N polymorphism and breast cancer susceptibility: a meta-analysis
Gao, L., Pan, X.-M., Sun, H., Wang, X., Rao, L., Li, L.-J., Liang, W., Lv, M., Yang, W., & Zhang, L. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-117 · Cited by 33
Foretinib (XL880): c-MET Inhibitor with Activity in Papillary Renal Cell Cancer
Logan, T. F. (2013) · Current Oncology Reports · doi:10.1007/s11912-013-0299-3 · Cited by 32
Inherited hepatocellular carcinoma
Villanueva, A., Newell, P., & Hoshida, Y. (2010) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2010.07.008 · Cited by 28
Genome-wide association studies of cancer: principles and potential utility.
Stadler, Z. K., Gallagher, D. J., Thom, P., & Offit, K. (2010) · PubMed · Cited by 24
Jóźwiak, S., Stein, K. F., & Kotulska, K. (2012) · Future Oncology · doi:10.2217/fon.12.146 · Cited by 21
Cited by
Pan-cancer analysis of whole genomes
The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, Aaltonen, L. A., Abascal, F., Abeshouse, A., Aburatani, H., Adams, D. J., Agrawal, N., Ahn, K. S., Ahn, S.-M., Aikata, H., et al. (2020) · Nature · doi:10.1038/s41586-020-1969-6 · Cited by 3,064
A compendium of mutational cancer driver genes
Martínez-Jiménez, F., Muiños, F., Sentís, I., Deu-Pons, J., Reyes-Salazar, I., Arnedo-Pac, C., Mularoni, L., Pich, O., Bonet, J., Kranas, H., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0290-x · Cited by 1,296
Translational biology of osteosarcoma
Kansara, M., Teng, M. W., Smyth, M. J., & Thomas, D. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3838 · Cited by 1,294
Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0003-x · Cited by 873
Pathogenic Germline Variants in 10,389 Adult Cancers
Huang, K.-L., Mashl, R. J., Wu, Y., Ritter, D. I., Wang, J., Oh, C., Paczkowska, M., Reynolds, S., Wyczalkowski, M. A., Oak, N., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.039 · Cited by 833
Metadata
- Authors
- Rahman, N.
- Venue
- Nature
- Published
- 2014-01-15
- Volume
- 505
- Issue
- 7483
- Pages
- 302-308
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2011830133
- Cited by
- 624
- References
- 111
- FWCI
- 29.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.